Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Mainly, some users experience mild injection site redness or soreness
This is described as part of provider-supervised discontinuation, not something to attempt alone
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide achieving up to 22.5% mean body weight reduction over 72 weeks at the highest dose
Am Heart J 159:612-619.e3
"This isn't a quick fix
US$ 23.49
US$ 21.61
US$ 25.06
US$ 29.05
